Vaxcyte director granted RSUs and stock options
Vaxcyte, Inc. director Halley E. Gilbert received new equity awards from the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Vaxcyte, Inc. director Halley E. Gilbert received new equity awards from the company. He was granted 2,265 restricted stock units, each representing one share of common stock, which will fully vest on the earlier of June 15, 2027 or the day prior to the next annual stockholder meeting, subject to his continuous service.
He also received stock options for 11,389 shares of common stock at an exercise price of $49.56 per share, expiring on June 15, 2036. These options vest monthly and will be fully vested on the same earlier-of-2027-or-next-meeting schedule. Following the RSU grant, he directly holds 12,481 shares of common stock.
Insider Trade Summary
Grant/Award: 13,654 shares
Grant/Award
2 txns
Insider
Gilbert Halley E
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 11,389 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 2,265 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 11,389 contracts (Direct);
Common Stock — 12,481 shares (Direct)
Footnotes (2)
- F1. Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.
- F2. The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.
Key Figures
RSUs granted: 2,265 units
Stock options granted: 11,389 options
Option exercise price: $49.56 per share
+2 more
5 metrics
RSUs granted
2,265 units
Restricted stock units granted to director on June 15, 2026
Stock options granted
11,389 options
Option grant to buy common stock on June 15, 2026
Option exercise price
$49.56 per share
Exercise price for 11,389 stock options
Option expiration date
June 15, 2036
Expiration of stock options granted to director
Shares held after grant
12,481 shares
Director’s direct common stock holdings following RSU grant
Key Terms
restricted stock units, RSUs, Stock Option (right to buy), exercise price, +1 more
5 terms
restricted stock units financial
"Represents the number of shares of Common Stock underlying restricted stock units ("RSUs")."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"Each RSU represents the contingent right to receive one share of the Issuer's Common Stock."
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
Stock Option (right to buy) financial
"Stock Option (right to buy)"
exercise price financial
"The shares of Common Stock subject to the option will vest monthly"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
continuous service financial
"subject to the Reporting Person's continuous service through such date."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Vaxcyte (PCVX) director Halley E. Gilbert report?
Halley E. Gilbert reported receiving equity awards from Vaxcyte, Inc., including restricted stock units and stock options. These awards are compensation grants, not open-market purchases or sales, and depend on his continued service with the company through the specified vesting dates.
How many Vaxcyte (PCVX) restricted stock units did the director receive?
He received 2,265 restricted stock units, each linked to one share of Vaxcyte common stock. These RSUs will fully vest on the earlier of June 15, 2027 or the day before the next annual stockholder meeting, assuming he continues serving the company until that date.
What stock options were granted to the Vaxcyte (PCVX) director and at what price?
He was granted options to purchase 11,389 shares of Vaxcyte common stock at an exercise price of $49.56 per share. These options vest monthly and will be fully vested by the earlier of June 15, 2027 or the day before the next annual stockholder meeting.
When do the new Vaxcyte (PCVX) RSUs and options vest for the director?
Both the 2,265 RSUs and the 11,389 stock options follow the same vesting framework. The RSUs fully vest and the options finish monthly vesting on the earlier of June 15, 2027 or the day prior to Vaxcyte’s next annual meeting, subject to continuous service.
What are the director’s Vaxcyte (PCVX) common stock holdings after this Form 4?
After the reported RSU grant, Halley E. Gilbert directly holds 12,481 shares of Vaxcyte common stock. This figure reflects his direct ownership position following the non-cash equity award recorded in the Form 4 insider transaction report.
When do the newly granted Vaxcyte (PCVX) stock options expire?
The stock options granted to Halley E. Gilbert expire on June 15, 2036. He can exercise them after vesting, at an exercise price of $49.56 per share, so long as he meets the service conditions and the options remain unexpired and outstanding.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates